Autopsy report · NCT00941135
Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab
Cause of deathNo reason given
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 4 years before it stopped.
- 70 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Fundacion Miguel Servet
- Sponsor type
- University, hospital or other
- Conditions
- Laryngeal Neoplasms
- Interventions
- Docetaxel+Cisplatin+5-FU+ Radiotherapy+Cetuximab
- Participants
- 70 (planned, not actual)
- Sites
- 4
- Countries
- Spain
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.